Veracyte, Inc. Common Stock VCYT
i
Market dataready · fetched 2026-11-03T14:43:31.461Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T14:43:00.980808723Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-03T14:43:30.923804+00:00
Veracyte, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 41.23 | 139.2% | 22.8% | |||
| 25Δ | 44.16 | 119.8% | 17.6% | |||
| 30Δ | 58.04 | 94.8% | 17.7% | 46.14 | 112.2% | 14.7% |
| 35Δ | 56.61 | 97.8% | 15.8% | 47.74 | 109.3% | 12.6% |
| 40Δ | 55.18 | 100.9% | 13.9% | 49.34 | 106.4% | 10.6% |
| 45Δ | 53.74 | 102.2% | 12.3% | 50.86 | 104.8% | 9.1% |
| 50Δ | 52.29 | 103.2% | 10.7% | 52.33 | 104.2% | 7.8% |
| 55Δ | 50.84 | 104.2% | 9.1% | 53.81 | 103.5% | 6.6% |
| 60Δ | 49.42 | 104.0% | 7.6% | 55.32 | 102.9% | 5.4% |
| 65Δ | 48.01 | 102.0% | 6.3% | 57.04 | 102.5% | 4.5% |
| 70Δ | 46.61 | 100.1% | 5.0% | 58.76 | 102.0% | 3.6% |
| 75Δ | 45.21 | 98.1% | 3.7% | 60.71 | 102.1% | 2.8% |
| 80Δ | 43.36 | 99.2% | 2.9% | 63.28 | 103.3% | 2.0% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 41.23
- IV
- 139.2%
- B/E move
- 22.8%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 44.16
- IV
- 119.8%
- B/E move
- 17.6%
30Δ
- Pseudo strike
- 58.04
- IV
- 94.8%
- B/E move
- 17.7%
- Pseudo strike
- 46.14
- IV
- 112.2%
- B/E move
- 14.7%
35Δ
- Pseudo strike
- 56.61
- IV
- 97.8%
- B/E move
- 15.8%
- Pseudo strike
- 47.74
- IV
- 109.3%
- B/E move
- 12.6%
40Δ
- Pseudo strike
- 55.18
- IV
- 100.9%
- B/E move
- 13.9%
- Pseudo strike
- 49.34
- IV
- 106.4%
- B/E move
- 10.6%
45Δ
- Pseudo strike
- 53.74
- IV
- 102.2%
- B/E move
- 12.3%
- Pseudo strike
- 50.86
- IV
- 104.8%
- B/E move
- 9.1%
50Δ
- Pseudo strike
- 52.29
- IV
- 103.2%
- B/E move
- 10.7%
- Pseudo strike
- 52.33
- IV
- 104.2%
- B/E move
- 7.8%
55Δ
- Pseudo strike
- 50.84
- IV
- 104.2%
- B/E move
- 9.1%
- Pseudo strike
- 53.81
- IV
- 103.5%
- B/E move
- 6.6%
60Δ
- Pseudo strike
- 49.42
- IV
- 104.0%
- B/E move
- 7.6%
- Pseudo strike
- 55.32
- IV
- 102.9%
- B/E move
- 5.4%
65Δ
- Pseudo strike
- 48.01
- IV
- 102.0%
- B/E move
- 6.3%
- Pseudo strike
- 57.04
- IV
- 102.5%
- B/E move
- 4.5%
70Δ
- Pseudo strike
- 46.61
- IV
- 100.1%
- B/E move
- 5.0%
- Pseudo strike
- 58.76
- IV
- 102.0%
- B/E move
- 3.6%
75Δ
- Pseudo strike
- 45.21
- IV
- 98.1%
- B/E move
- 3.7%
- Pseudo strike
- 60.71
- IV
- 102.1%
- B/E move
- 2.8%
80Δ
- Pseudo strike
- 43.36
- IV
- 99.2%
- B/E move
- 2.9%
- Pseudo strike
- 63.28
- IV
- 103.3%
- B/E move
- 2.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 74.89% | |
| 74.04% | |
| 70.14% | |
| 74.40% | |
| 69.51% | |
| 67.59% | |
| 70.06% | |
| 70.75% | |
| 69.56% | |
| 74.04% |
Diagnostics & Research
WAT
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
More →WGS
Sema4 Holdings Corp. The company is headquartered in Stamford, Connecticut.
More →XGN
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The…
More →A
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global…
More →ADPT
Description unavailable
More →BLLN
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
More →